Brown Advisory’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-503
Closed -$82.3K 1259
2024
Q2
$82.3K Sell
503
-101,142
-100% -$14.4M ﹤0.01% 1202
2024
Q1
$15.5M Sell
101,645
-61,811
-38% -$10.3M 0.02% 352
2023
Q4
$51.3M Buy
163,456
+4,667
+3% +$1.69M 0.07% 198
2023
Q3
$70.5M Buy
158,789
+2,813
+2% +$1.27M 0.12% 147
2023
Q2
$67.6M Buy
155,976
+3,604
+2% +$2.03M 0.11% 161
2023
Q1
$90.5M Buy
152,372
+1,348
+0.9% +$755K 0.15% 125
2022
Q4
$60.9M Buy
151,024
+3,213
+2% +$1.51M 0.11% 161
2022
Q3
$86.5M Buy
147,811
+2,016
+1% +$1.21M 0.17% 116
2022
Q2
$79.6M Buy
145,795
+554
+0.4% +$280K 0.15% 132
2022
Q1
$92M Buy
145,241
+9,523
+7% +$4.91M 0.14% 127
2021
Q4
$91.6M Sell
135,718
-1,465
-1% -$891K 0.11% 127
2021
Q3
$89.9M Buy
137,183
+11,972
+10% +$10.2M 0.13% 128
2021
Q2
$127M Buy
+125,211
New +$110M 0.19% 102

Other funds holding AGL

Brown Advisory's AGL Position: Q3 2024 in Review

Brown Advisory sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 503 shares — an estimated $82.3K sold.

Brown Advisory first reported a position in AGL in Q2 2021 and held it in 13 quarters. The position peaked at $127M in Q2 2021. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • Brown Advisory reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
  • Brown Advisory sold 503 Agilon Health shares in Q3 2024, an estimated $82.3K.
  • Brown Advisory first reported a position in Agilon Health in Q2 2021 and held it in 13 quarters.
  • Brown Advisory's Agilon Health position peaked at $127M in Q2 2021.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on Brown Advisory's 13F filing for Q3 2024, filed 13 Nov 2024.